ประเทศ: สหรัฐอเมริกา
ภาษา: อังกฤษ
แหล่งที่มา: NLM (National Library of Medicine)
levofloxacin (UNII: 6GNT3Y5LMF) (Levofloxacin Anhydrous - UNII:RIX4E89Y14)
WG Critical Care, LLC
levofloxacin
Levofloxacin Anhydrous 5 mg in 1 mL
INTRAVENOUS
PRESCRIPTION DRUG
Levofloxacin Injection in 5% dextrose is indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. Levofloxacin Injection is indicated when intravenous administration offers a route of administration advantageous to the patient (e.g., patient cannot tolerate an oral dosage form). Levofloxacin is indicated for the treatment of nosocomial pneumonia due to methicillin-susceptible Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, or Streptococcus pneumoniae . Adjunctive therapy should be used as clinically indicated. Where Pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see Clinical Studies (14.1)] . Levofloxacin is indicated for the treatment of community-acquired pneumonia due to methicillin-suscep
Levofloxacin Injection in 5% dextrose is supplied as a single-dose, premixed solution in flexible containers. Each bag contains a dilute solution with the equivalent of 250, 500, or 750 mg of levofloxacin, respectively, in 5% Dextrose (D5 W). NDC Strength Package 44567-435-24 250 mg per 50 mL 24 bags per carton 44567-436-24 500 mg per 100 mL 24 bags per carton 44567-437-24 750 mg per 150 mL 24 bags per carton Storage Conditions Store at or below 25°C (77°F); however, brief exposure up to 40°C (104°F) does not adversely affect the product. Avoid excessive heat. Protect from freezing. Protect from light. Keep out of reach of children. Sterile, Nonpyrogenic, Preservative-free, PVC-free, DEHP-free. The container closure is not made with natural rubber latex.
Abbreviated New Drug Application
LEVOFLOXACIN- LEVOFLOXACIN INJECTION, SOLUTION WG Critical Care, LLC ---------- MEDICATION GUIDE LEVOFLOXACIN (lee voe FLOX a sin) INJECTION in 5% Dextrose For Intravenous Use Read this Medication Guide before you start taking LEVOFLOXACIN and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your healthcare provider about your medical condition or your treatment. What is the most important information I should know about LEVOFLOXACIN? LEVOFLOXACIN, a fluoroquinolone antibiotic, can cause serious side effects. Some of these serious side effects can happen at the same time and could result in death. If you have any of the following serious side effects while you take LEVOFLOXACIN, you should stop taking LEVOFLOXACIN immediately and get medical help right away. 1. Tendon rupture or swelling of the tendon (tendinitis). • Tendon problems can happen in people of all ages who take LEVOFLOXACIN. Tendons are tough cords of tissue that connect muscles to bones. Some tendon problems include pain, swelling, tears, and swelling of tendons including the back of the ankle (Achilles), shoulder, hand, or other tendon sites. • The risk of getting tendon problems while you take LEVOFLOXACIN is higher if you: • are over 60 years of age • are taking steroids (corticosteroids) • have had a kidney, heart or lung transplant. • Tendon problems can happen in people who do not have the above risk factors when they take LEVOFLOXACIN. • Other reasons that can increase your risk of tendon problems can include: • physical activity or exercise • kidney failure • tendon problems in the past, such as in people with rheumatoid arthritis (RA) • Stop taking LEVOFLOXACIN immediately and get medical help right away at the first sign of tendon pain, swelling or inflammation. Avoid exercise and using the affected area. The most common area of pain and swelling is the Achilles tendon at the back of your ankle. This can also happen with other tendons. You may need a อ่านเอกสารฉบับเต็ม
LEVOFLOXACIN- LEVOFLOXACIN INJECTION, SOLUTION WG CRITICAL CARE, LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE LEVOFLOXACIN INJECTION IN 5% DEXTROSE SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR LEVOFLOXACIN INJECTION IN 5% DEXTROSE. LEVOFLOXACIN INJECTION IN 5% DEXTROSE, FOR INTRAVENOUS USE INITIAL U.S. APPROVAL: 1996 WARNING: SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRAL NERVOUS SYSTEM EFFECTS AND EXACERBATION OF MYASTHENIA GRAVIS _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ • DISCONTINUE LEVOFLOXACIN INJECTION IMMEDIATELY AND AVOID USE OF FLUOROQUINOLONES, INCLUDING LEVOFLOXACIN INJECTION IN 5% DEXTROSE, IN PATIENTS WHO EXPERIENCE ANY OF THESE SERIOUS ADVERSE REACTIONS (5.1) • • RECENT MAJOR CHANGES Warnings and Precautions (5.4, 5.8, 5.13) 3/2019 INDICATIONS AND USAGE Levofloxacin is a fluoroquinolone antibacterial indicated in adults (≥18 years of age) with infections caused by designated, susceptible bacteria (1, 12.4). • • • • • • • • • FLUOROQUINOLONES, INCLUDING LEVOFLOXACIN INJECTION IN 5% DEXTROSE, HAVE BEEN ASSOCIATED WITH DISABLING AND POTENTIALLY IRREVERSIBLE SERIOUS ADVERSE REACTIONS THAT HAVE OCCURRED TOGETHER (5.1), INCLUDING: • • • TENDINITIS AND TENDON RUPTURE (5.2) PERIPHERAL NEUROPATHY (5.3) CENTRAL NERVOUS SYSTEM EFFECTS (5.4) FLUOROQUINOLONES, INCLUDING LEVOFLOXACIN INJECTION IN 5% DEXTROSE, MAY EXACERBATE MUSCLE WEAKNESS IN PATIENTS WITH MYASTHENIA GRAVIS. AVOID LEVOFLOXACIN INJECTION IN 5% DEXTROSE IN PATIENTS WITH A KNOWN HISTORY OF MYASTHENIA GRAVIS _[SEE WARNINGS AND PRECAUTIONS (5.5)]_. BECAUSE FLUOROQUINOLONES, INCLUDING LEVOFLOXACIN INJECTION IN 5% DEXTROSE, HAVE BEEN ASSOCIATED WITH SERIOUS ADVERSE REACTIONS (5.1 TO 5.15), RESERVE LEVOFLOXACIN INJECTION IN 5% DEXTROSE FOR USE IN PATIENTS WHO HAVE NO ALTERNATIVE TREATMENT OPTIONS FOR THE FOLLOWING INDICATIONS: • • • UNCOMPLICATED URINARY TRACT อ่านเอกสารฉบับเต็ม